Pier Luigi Tazzari
Overview
Explore the profile of Pier Luigi Tazzari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chatgilialoglu A, Rossi M, Alviano F, Poggi P, Zannini C, Marchionni C, et al.
Stem Cell Res Ther
. 2017 Feb;
8(1):31.
PMID: 28173875
Background: The study of lipid metabolism in stem cell physiology has recently raised great interest. The role of lipids goes beyond the mere structural involvement in assembling extra- and intra-cellular...
12.
Carnicelli D, Arfilli V, Ricci F, Velati C, Tazzari P, Brigotti M
J Immunol
. 2015 Dec;
196(3):1177-85.
PMID: 26695372
Hemolytic uremic syndrome (HUS) is the life-threatenig sequela of intestinal infections by Shiga toxin (Stx)-producing Escherichia coli (STEC) in children. Human neutrophils specifically bind Stx through TLR4, the receptor of...
13.
Tolomelli G, Tazzari P, Paolucci M, Arpinati M, Landini M, Pagliaro P
Blood Transfus
. 2014 Jun;
12(4):611-4.
PMID: 24960659
No abstract available.
14.
Pagliaro P, Belardinelli A, Boko V, Salamon P, Manfroi S, Tazzari P
Blood Transfus
. 2014 Jun;
12(4):458-63.
PMID: 24960642
Introduction: Assessing blood-donor haemoglobin (Hb) is a worldwide screening requirement against inappropriate donation. The pre-donation Hb (which should be at least 12.5 g/dL in women and 13.5 g/dL in men)...
15.
Martelli A, Lonetti A, Buontempo F, Ricci F, Tazzari P, Evangelisti C, et al.
Adv Biol Regul
. 2014 May;
56:6-21.
PMID: 24819383
Leukemia initiating cells (LICs) represent a reservoir that is believed to drive relapse and resistance to chemotherapy in blood malignant disorders. T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive neoplastic...
16.
La Manna G, Ghinatti G, Tazzari P, Alviano F, Ricci F, Capelli I, et al.
PLoS One
. 2014 Mar;
9(2):e89497.
PMID: 24586826
Background: Neutrophil gelatinase-associated lipocalin (NGAL) is emerging as a mediator of various biological and pathological states. However, the specific biological role of this molecule remains unclear, as it serves as...
17.
Valente S, Alviano F, Ciavarella C, Buzzi M, Ricci F, Tazzari P, et al.
Stem Cell Res Ther
. 2014 Jan;
5(1):8.
PMID: 24429026
Introduction: Regenerative medicine challenges researchers to find noncontroversial, safe and abundant stem cell sources. In this context, harvesting from asystolic donors could represent an innovative and unlimited reservoir of different...
18.
Brigotti M, Carnicelli D, Arfilli V, Tamassia N, Borsetti F, Fabbri E, et al.
J Immunol
. 2013 Sep;
191(9):4748-58.
PMID: 24068665
Hemolytic uremic syndrome (HUS) caused by intestinal Shiga toxin-producing Escherichia coli infections is a worldwide health problem, as dramatically exemplified by the German outbreak occurred in summer 2011 and by...
19.
Brigotti M, Arfilli V, Carnicelli D, Rocchi L, Calcabrini C, Ricci F, et al.
Toxins (Basel)
. 2013 Feb;
5(2):431-44.
PMID: 23430607
Shiga toxin 1 (Stx1), produced by pathogenic Escherichia coli, targets a restricted subset of human cells, which possess the receptor globotriaosylceramide (Gb3Cer/CD77), causing hemolytic uremic syndrome. In spite of the...
20.
Chiarini F, Lonetti A, Teti G, Orsini E, Bressanin D, Cappellini A, et al.
Oncotarget
. 2012 Dec;
3(12):1615-28.
PMID: 23271044
Signaling through the phosphatidylinositol 3-kinase (PI3K) pathway and its downstream effectors, Akt and mechanistic target of rapamycin (mTOR), is aberrantly activated in acute myeloid leukemia (AML) patients, where it contributes...